PMC:7253482 / 1491-2299
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 67 | 690-695 | Gene | denotes | spike | Gene:43740568 |
| 68 | 0-13 | Species | denotes | Coronaviruses | Tax:11118 |
| 69 | 15-19 | Species | denotes | CoVs | Tax:11118 |
| 70 | 115-121 | Species | denotes | humans | Tax:9606 |
| 71 | 132-136 | Species | denotes | CoVs | Tax:11118 |
| 72 | 178-183 | Species | denotes | human | Tax:9606 |
| 73 | 223-268 | Species | denotes | severe acute respiratory syndrome coronavirus | Tax:694009 |
| 74 | 270-278 | Species | denotes | SARS-CoV | Tax:694009 |
| 75 | 290-345 | Species | denotes | Middle East respiratory syndrome coronavirus (MERS-CoV) | Tax:1335626 |
| 76 | 377-387 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 77 | 521-527 | Species | denotes | humans | Tax:9606 |
| 78 | 70-91 | Disease | denotes | respiratory disorders | MESH:D012131 |
| 79 | 402-411 | Disease | denotes | mortality | MESH:D003643 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T10 | 700-708 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T6 | 70-91 | Disease | denotes | respiratory disorders | http://purl.obolibrary.org/obo/MONDO_0005087 |
| T7 | 223-256 | Disease | denotes | severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T8 | 270-278 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T9 | 270-274 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T10 | 377-385 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T11 | 377-381 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T8 | 147-148 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T9 | 178-183 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
| T10 | 521-527 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | humans |
| T11 | 677-682 | http://purl.obolibrary.org/obo/CLO_0009985 | denotes | focus |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T10 | 700-708 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-sample-PD-IDO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T6 | 35-44 | http://purl.obolibrary.org/obo/IDO_0000528 | denotes | pathogens |
| T7 | 82-91 | http://purl.obolibrary.org/obo/OGMS_0000045 | denotes | disorders |
| T8 | 630-639 | http://purl.obolibrary.org/obo/IDO_0000528 | denotes | pathogens |
LitCovid-sample-Enju
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T225 | 0-13 | NNS | denotes | Coronaviruses |
| T226 | 14-15 | -LRB- | denotes | ( |
| T227 | 15-19 | NNS | denotes | CoVs |
| T228 | 19-20 | -RRB- | denotes | ) |
| T229 | 21-24 | VBP | denotes | are |
| T230 | 25-34 | VBN | denotes | enveloped |
| T231 | 35-44 | NNS | denotes | pathogens |
| T232 | 45-56 | JJ | denotes | responsible |
| T233 | 57-60 | IN | denotes | for |
| T234 | 61-69 | JJ | denotes | multiple |
| T235 | 70-81 | JJ | denotes | respiratory |
| T236 | 82-91 | NNS | denotes | disorders |
| T237 | 92-94 | IN | denotes | of |
| T238 | 95-102 | VBG | denotes | varying |
| T239 | 103-111 | NN | denotes | severity |
| T240 | 112-114 | IN | denotes | in |
| T241 | 115-122 | NN | denotes | humans1 |
| T242 | 124-131 | JJ | denotes | Certain |
| T243 | 132-136 | NNS | denotes | CoVs |
| T244 | 137-146 | VBP | denotes | represent |
| T245 | 147-148 | DT | denotes | a |
| T246 | 149-160 | JJ | denotes | significant |
| T247 | 161-167 | NN | denotes | threat |
| T248 | 168-170 | TO | denotes | to |
| T249 | 171-177 | JJ | denotes | global |
| T250 | 178-183 | JJ | denotes | human |
| T251 | 184-190 | NN | denotes | health |
| T252 | 190-191 | -COMMA- | denotes | , |
| T253 | 192-194 | IN | denotes | as |
| T254 | 195-206 | VBN | denotes | illustrated |
| T255 | 207-209 | IN | denotes | by |
| T256 | 210-219 | NNS | denotes | outbreaks |
| T257 | 220-222 | IN | denotes | of |
| T258 | 223-229 | JJ | denotes | severe |
| T259 | 230-235 | JJ | denotes | acute |
| T260 | 236-247 | JJ | denotes | respiratory |
| T261 | 248-256 | NN | denotes | syndrome |
| T262 | 257-268 | NN | denotes | coronavirus |
| T263 | 269-270 | -LRB- | denotes | ( |
| T264 | 270-278 | NN | denotes | SARS-CoV |
| T265 | 278-279 | -RRB- | denotes | ) |
| T266 | 280-282 | IN | denotes | in |
| T267 | 283-288 | CD | denotes | 20032 |
| T268 | 288-289 | -COMMA- | denotes | , |
| T269 | 290-296 | NNP | denotes | Middle |
| T270 | 297-301 | NNP | denotes | East |
| T271 | 302-313 | JJ | denotes | respiratory |
| T272 | 314-322 | NN | denotes | syndrome |
| T273 | 323-334 | NN | denotes | coronavirus |
| T274 | 335-336 | -LRB- | denotes | ( |
| T275 | 336-344 | NN | denotes | MERS-CoV |
| T276 | 344-345 | -RRB- | denotes | ) |
| T277 | 346-348 | IN | denotes | in |
| T278 | 349-354 | CD | denotes | 20123 |
| T279 | 354-355 | -COMMA- | denotes | , |
| T280 | 356-359 | CC | denotes | and |
| T281 | 360-364 | RBS | denotes | most |
| T282 | 365-373 | RB | denotes | recently |
| T283 | 374-376 | IN | denotes | of |
| T284 | 377-388 | NN | denotes | SARS-CoV-24 |
| T285 | 390-395 | VBN | denotes | Given |
| T286 | 396-401 | PRP-DOLLAR- | denotes | their |
| T287 | 402-411 | NN | denotes | mortality |
| T288 | 412-417 | NNS | denotes | rates |
| T289 | 417-418 | -COMMA- | denotes | , |
| T290 | 419-422 | DT | denotes | the |
| T291 | 423-430 | JJ | denotes | current |
| T292 | 431-435 | NN | denotes | lack |
| T293 | 436-438 | IN | denotes | of |
| T294 | 439-447 | VBN | denotes | targeted |
| T295 | 448-458 | NNS | denotes | treatments |
| T296 | 459-462 | CC | denotes | and |
| T297 | 463-471 | JJ | denotes | licensed |
| T298 | 472-480 | NNS | denotes | vaccines |
| T299 | 480-481 | -COMMA- | denotes | , |
| T300 | 482-485 | CC | denotes | and |
| T301 | 486-491 | PRP-DOLLAR- | denotes | their |
| T302 | 492-500 | NN | denotes | capacity |
| T303 | 501-503 | TO | denotes | to |
| T304 | 504-512 | VB | denotes | transmit |
| T305 | 513-520 | IN | denotes | between |
| T306 | 521-527 | NNS | denotes | humans |
| T307 | 528-531 | CC | denotes | and |
| T308 | 532-538 | IN | denotes | across |
| T309 | 539-546 | NNS | denotes | species |
| T310 | 547-558 | NN | denotes | barriers5,6 |
| T311 | 558-559 | -COMMA- | denotes | , |
| T312 | 560-565 | EX | denotes | there |
| T313 | 566-568 | VBZ | denotes | is |
| T314 | 569-571 | DT | denotes | an |
| T315 | 572-578 | JJ | denotes | urgent |
| T316 | 579-583 | NN | denotes | need |
| T317 | 584-587 | IN | denotes | for |
| T318 | 588-597 | JJ | denotes | effective |
| T319 | 598-613 | NNS | denotes | countermeasures |
| T320 | 614-616 | TO | denotes | to |
| T321 | 617-623 | VB | denotes | combat |
| T322 | 624-629 | DT | denotes | these |
| T323 | 630-639 | NNS | denotes | pathogens |
| T324 | 641-648 | VBG | denotes | Ongoing |
| T325 | 649-656 | NN | denotes | vaccine |
| T326 | 657-668 | NN | denotes | development |
| T327 | 669-676 | NNS | denotes | efforts |
| T328 | 677-682 | NN | denotes | focus |
| T329 | 683-685 | IN | denotes | on |
| T330 | 686-689 | DT | denotes | the |
| T331 | 690-695 | NN | denotes | spike |
| T332 | 696-697 | -LRB- | denotes | ( |
| T333 | 697-698 | NN | denotes | S |
| T334 | 698-699 | -RRB- | denotes | ) |
| T335 | 700-708 | NNS | denotes | proteins |
| T336 | 709-713 | WDT | denotes | that |
| T337 | 714-722 | VBP | denotes | protrude |
| T338 | 723-727 | IN | denotes | from |
| T339 | 728-731 | DT | denotes | the |
| T340 | 732-737 | JJ | denotes | viral |
| T341 | 738-746 | NN | denotes | envelope |
| T342 | 747-750 | CC | denotes | and |
| T343 | 751-761 | VB | denotes | constitute |
| T344 | 762-765 | DT | denotes | the |
| T345 | 766-770 | JJ | denotes | main |
| T346 | 771-777 | NN | denotes | target |
| T347 | 778-780 | IN | denotes | of |
| T348 | 781-793 | VBG | denotes | neutralizing |
| T349 | 794-807 | NN | denotes | antibodies7,8 |
| R221 | T225 | T226 | arg1Of | Coronaviruses,( |
| R222 | T227 | T226 | arg2Of | CoVs,( |
| R223 | T228 | T226 | arg3Of | ),( |
| R224 | T225 | T229 | arg1Of | Coronaviruses,are |
| R225 | T231 | T229 | arg2Of | pathogens,are |
| R226 | T231 | T230 | arg2Of | pathogens,enveloped |
| R227 | T231 | T232 | arg1Of | pathogens,responsible |
| R228 | T232 | T233 | arg1Of | responsible,for |
| R229 | T236 | T233 | arg2Of | disorders,for |
| R230 | T236 | T234 | arg1Of | disorders,multiple |
| R231 | T236 | T235 | arg1Of | disorders,respiratory |
| R232 | T236 | T237 | arg1Of | disorders,of |
| R233 | T239 | T237 | arg2Of | severity,of |
| R234 | T239 | T238 | arg1Of | severity,varying |
| R235 | T239 | T240 | arg1Of | severity,in |
| R236 | T241 | T240 | arg2Of | humans1,in |
| R237 | T243 | T242 | arg1Of | CoVs,Certain |
| R238 | T243 | T244 | arg1Of | CoVs,represent |
| R239 | T247 | T244 | arg2Of | threat,represent |
| R240 | T247 | T245 | arg1Of | threat,a |
| R241 | T247 | T246 | arg1Of | threat,significant |
| R242 | T247 | T248 | arg1Of | threat,to |
| R243 | T251 | T248 | arg2Of | health,to |
| R244 | T251 | T249 | arg1Of | health,global |
| R245 | T251 | T250 | arg1Of | health,human |
| R246 | T244 | T252 | arg1Of | represent,"," |
| R247 | T244 | T253 | arg1Of | represent,as |
| R248 | T254 | T253 | arg2Of | illustrated,as |
| R249 | T256 | T254 | arg1Of | outbreaks,illustrated |
| R250 | T256 | T255 | arg2Of | outbreaks,by |
| R251 | T256 | T257 | arg1Of | outbreaks,of |
| R252 | T262 | T257 | arg2Of | coronavirus,of |
| R253 | T262 | T258 | arg1Of | coronavirus,severe |
| R254 | T262 | T259 | arg1Of | coronavirus,acute |
| R255 | T262 | T260 | arg1Of | coronavirus,respiratory |
| R256 | T262 | T261 | arg1Of | coronavirus,syndrome |
| R257 | T262 | T263 | arg1Of | coronavirus,( |
| R258 | T264 | T263 | arg2Of | SARS-CoV,( |
| R259 | T265 | T263 | arg3Of | ),( |
| R260 | T262 | T266 | arg1Of | coronavirus,in |
| R261 | T267 | T266 | arg2Of | 20032,in |
| R262 | T256 | T268 | arg1Of | outbreaks,"," |
| R263 | T273 | T268 | arg2Of | coronavirus,"," |
| R264 | T270 | T269 | arg1Of | East,Middle |
| R265 | T273 | T270 | arg1Of | coronavirus,East |
| R266 | T273 | T271 | arg1Of | coronavirus,respiratory |
| R267 | T273 | T272 | arg1Of | coronavirus,syndrome |
| R268 | T273 | T274 | arg1Of | coronavirus,( |
| R269 | T275 | T274 | arg2Of | MERS-CoV,( |
| R270 | T276 | T274 | arg3Of | ),( |
| R271 | T273 | T277 | arg1Of | coronavirus,in |
| R272 | T278 | T277 | arg2Of | 20123,in |
| R273 | T280 | T279 | arg1Of | and,"," |
| R274 | T277 | T280 | arg1Of | in,and |
| R275 | T283 | T280 | arg2Of | of,and |
| R276 | T282 | T281 | arg1Of | recently,most |
| R277 | T283 | T282 | arg1Of | of,recently |
| R278 | T273 | T283 | arg1Of | coronavirus,of |
| R279 | T284 | T283 | arg2Of | SARS-CoV-24,of |
| R280 | T313 | T285 | arg1Of | is,Given |
| R281 | T300 | T285 | arg2Of | and,Given |
| R282 | T288 | T286 | arg1Of | rates,their |
| R283 | T288 | T287 | arg1Of | rates,mortality |
| R284 | T288 | T289 | arg1Of | rates,"," |
| R285 | T292 | T289 | arg2Of | lack,"," |
| R286 | T292 | T290 | arg1Of | lack,the |
| R287 | T292 | T291 | arg1Of | lack,current |
| R288 | T292 | T293 | arg1Of | lack,of |
| R289 | T296 | T293 | arg2Of | and,of |
| R290 | T295 | T294 | arg2Of | treatments,targeted |
| R291 | T295 | T296 | arg1Of | treatments,and |
| R292 | T298 | T296 | arg2Of | vaccines,and |
| R293 | T298 | T297 | arg1Of | vaccines,licensed |
| R294 | T300 | T299 | arg1Of | and,"," |
| R295 | T289 | T300 | arg1Of | ",",and |
| R296 | T302 | T300 | arg2Of | capacity,and |
| R297 | T302 | T301 | arg1Of | capacity,their |
| R298 | T304 | T303 | arg1Of | transmit,to |
| R299 | T302 | T303 | modOf | capacity,to |
| R300 | T304 | T305 | arg1Of | transmit,between |
| R301 | T306 | T305 | arg2Of | humans,between |
| R302 | T285 | T307 | arg1Of | Given,and |
| R303 | T308 | T307 | arg2Of | across,and |
| R304 | T313 | T308 | arg1Of | is,across |
| R305 | T310 | T308 | arg2Of | "barriers5,6",across |
| R306 | T310 | T309 | arg1Of | "barriers5,6",species |
| R307 | T313 | T311 | arg1Of | is,"," |
| R308 | T312 | T313 | arg1Of | there,is |
| R309 | T316 | T313 | arg2Of | need,is |
| R310 | T316 | T314 | arg1Of | need,an |
| R311 | T316 | T315 | arg1Of | need,urgent |
| R312 | T316 | T317 | arg1Of | need,for |
| R313 | T319 | T317 | arg2Of | countermeasures,for |
| R314 | T321 | T317 | arg3Of | combat,for |
| R315 | T319 | T318 | arg1Of | countermeasures,effective |
| R316 | T321 | T320 | arg1Of | combat,to |
| R317 | T319 | T321 | arg1Of | countermeasures,combat |
| R318 | T323 | T321 | arg2Of | pathogens,combat |
| R319 | T323 | T322 | arg1Of | pathogens,these |
| R320 | T328 | T324 | arg1Of | focus,Ongoing |
| R321 | T328 | T325 | arg1Of | focus,vaccine |
| R322 | T328 | T326 | arg1Of | focus,development |
| R323 | T328 | T327 | arg1Of | focus,efforts |
| R324 | T328 | T329 | arg1Of | focus,on |
| R325 | T335 | T329 | arg2Of | proteins,on |
| R326 | T335 | T330 | arg1Of | proteins,the |
| R327 | T335 | T331 | arg1Of | proteins,spike |
| R328 | T335 | T332 | arg1Of | proteins,( |
| R329 | T333 | T332 | arg2Of | S,( |
| R330 | T334 | T332 | arg3Of | ),( |
| R331 | T335 | T336 | arg1Of | proteins,that |
| R332 | T335 | T337 | arg1Of | proteins,protrude |
| R333 | T337 | T338 | arg1Of | protrude,from |
| R334 | T341 | T338 | arg2Of | envelope,from |
| R335 | T341 | T339 | arg1Of | envelope,the |
| R336 | T341 | T340 | arg1Of | envelope,viral |
| R337 | T337 | T342 | arg1Of | protrude,and |
| R338 | T343 | T342 | arg2Of | constitute,and |
| R339 | T335 | T343 | arg1Of | proteins,constitute |
| R340 | T346 | T343 | arg2Of | target,constitute |
| R341 | T346 | T344 | arg1Of | target,the |
| R342 | T346 | T345 | arg1Of | target,main |
| R343 | T346 | T347 | arg1Of | target,of |
| R344 | T348 | T347 | arg2Of | neutralizing,of |
| R345 | T349 | T348 | arg2Of | "antibodies7,8",neutralizing |
LitCovid-sample-PD-FMA
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T10 | 700-708 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-sample-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T10 | 700-708 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-sample-PD-NCBITaxon
| Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
|---|---|---|---|---|---|
| T11 | 178-183 | Species | denotes | human | NCBItxid:9606 |
| T12 | 223-256 | Species | denotes | severe acute respiratory syndrome | NCBItxid:694009 |
| T13 | 270-278 | Species | denotes | SARS-CoV | NCBItxid:694009 |
| T14 | 270-274 | Species | denotes | SARS | NCBItxid:694009 |
| T15 | 290-334 | Species | denotes | Middle East respiratory syndrome coronavirus | NCBItxid:1335626 |
| T16 | 336-344 | Species | denotes | MERS-CoV | NCBItxid:1335626 |
| T17 | 377-385 | Species | denotes | SARS-CoV | NCBItxid:694009 |
| T18 | 377-381 | Species | denotes | SARS | NCBItxid:694009 |
| T19 | 521-527 | Species | denotes | humans | NCBItxid:9605 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T12 | 0-123 | Sentence | denotes | Coronaviruses (CoVs) are enveloped pathogens responsible for multiple respiratory disorders of varying severity in humans1. |
| T13 | 124-389 | Sentence | denotes | Certain CoVs represent a significant threat to global human health, as illustrated by outbreaks of severe acute respiratory syndrome coronavirus (SARS-CoV) in 20032, Middle East respiratory syndrome coronavirus (MERS-CoV) in 20123, and most recently of SARS-CoV-24. |
| T14 | 390-640 | Sentence | denotes | Given their mortality rates, the current lack of targeted treatments and licensed vaccines, and their capacity to transmit between humans and across species barriers5,6, there is an urgent need for effective countermeasures to combat these pathogens. |
| T15 | 641-808 | Sentence | denotes | Ongoing vaccine development efforts focus on the spike (S) proteins that protrude from the viral envelope and constitute the main target of neutralizing antibodies7,8. |
LitCovid-sample-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T6 | 70-91 | Disease | denotes | respiratory disorders | http://purl.obolibrary.org/obo/MONDO_0005087 |
| T7 | 223-256 | Disease | denotes | severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T8 | 270-278 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T9 | 270-274 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T10 | 377-385 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T11 | 377-381 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 78 | 70-91 | Disease | denotes | respiratory disorders | MESH:D012131 |
| 70 | 115-121 | Species | denotes | humans | Tax:9606 |
| 71 | 132-136 | Species | denotes | CoVs | Tax:11118 |
| 72 | 178-183 | Species | denotes | human | Tax:9606 |
| 73 | 223-268 | Species | denotes | severe acute respiratory syndrome coronavirus | Tax:694009 |
| 74 | 270-278 | Species | denotes | SARS-CoV | Tax:694009 |
| 75 | 290-345 | Species | denotes | Middle East respiratory syndrome coronavirus (MERS-CoV) | Tax:1335626 |
| 76 | 377-387 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 79 | 402-411 | Disease | denotes | mortality | MESH:D003643 |
| 77 | 521-527 | Species | denotes | humans | Tax:9606 |
| 67 | 690-695 | Gene | denotes | spike | Gene:43740568 |
LitCovid-sample-UniProt
| Id | Subject | Object | Predicate | Lexical cue | uniprot_id |
|---|---|---|---|---|---|
| T714 | 696-708 | Protein | denotes | (S) proteins | https://www.uniprot.org/uniprot/Q9UIP0|https://www.uniprot.org/uniprot/Q9UIN9|https://www.uniprot.org/uniprot/Q9UIN8|https://www.uniprot.org/uniprot/Q9UIN7|https://www.uniprot.org/uniprot/Q9UIN6|https://www.uniprot.org/uniprot/Q9UBH8|https://www.uniprot.org/uniprot/Q9NRH8|https://www.uniprot.org/uniprot/Q9NRH7|https://www.uniprot.org/uniprot/Q9NRH6|https://www.uniprot.org/uniprot/Q9NRH5|https://www.uniprot.org/uniprot/Q9NRH4|https://www.uniprot.org/uniprot/Q9NPG5|https://www.uniprot.org/uniprot/Q9NPE0|https://www.uniprot.org/uniprot/Q9NP52|https://www.uniprot.org/uniprot/Q95IF9|https://www.uniprot.org/uniprot/Q8N5P3|https://www.uniprot.org/uniprot/Q8IZU6|https://www.uniprot.org/uniprot/Q8IZU5|https://www.uniprot.org/uniprot/Q8IZU4|https://www.uniprot.org/uniprot/Q86Z04|https://www.uniprot.org/uniprot/Q7YR44|https://www.uniprot.org/uniprot/Q7LA71|https://www.uniprot.org/uniprot/Q7LA70|https://www.uniprot.org/uniprot/Q5STD2|https://www.uniprot.org/uniprot/Q5SQ85|https://www.uniprot.org/uniprot/Q1XI16|https://www.uniprot.org/uniprot/Q1XI12|https://www.uniprot.org/uniprot/Q15517|https://www.uniprot.org/uniprot/O43509|https://www.uniprot.org/uniprot/O19084|https://www.uniprot.org/uniprot/B0UYZ7|https://www.uniprot.org/uniprot/B0S7V2|https://www.uniprot.org/uniprot/A5A6L9 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T12 | 0-123 | Sentence | denotes | Coronaviruses (CoVs) are enveloped pathogens responsible for multiple respiratory disorders of varying severity in humans1. |
| T13 | 124-389 | Sentence | denotes | Certain CoVs represent a significant threat to global human health, as illustrated by outbreaks of severe acute respiratory syndrome coronavirus (SARS-CoV) in 20032, Middle East respiratory syndrome coronavirus (MERS-CoV) in 20123, and most recently of SARS-CoV-24. |
| T14 | 390-640 | Sentence | denotes | Given their mortality rates, the current lack of targeted treatments and licensed vaccines, and their capacity to transmit between humans and across species barriers5,6, there is an urgent need for effective countermeasures to combat these pathogens. |
| T15 | 641-808 | Sentence | denotes | Ongoing vaccine development efforts focus on the spike (S) proteins that protrude from the viral envelope and constitute the main target of neutralizing antibodies7,8. |